Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/3/2025

Role of HDL in Cardiovascular Health

Primary Functions of HDL

  • HDL is important in reverse-cholesterol transport, bringing cholesterol from arterial deposits to the liver for processing, where it is converted to useful metabolites and eventually cleared from the body via bile secretions 1
  • HDL exhibits anti-inflammatory properties that help protect the vascular endothelium and reduce atherosclerotic processes 2
  • HDL demonstrates antioxidant capabilities, particularly through associated proteins like Paraoxonase 1 (PON1), which can metabolize oxidized lipids in LDL particles 2
  • HDL influences immune function, glucose metabolism, and platelet function, extending its protective effects beyond simple cholesterol transport 1
  • HDL promotes endothelial nitric oxide production, which supports vasodilation and vascular health 2

HDL Structure and Composition

  • HDL contains various apolipoproteins, with apolipoprotein A-I being a major protein component that can affect HDL particle size and stability 2
  • A family of lipoprotein lipases, including hepatic lipase and endothelial lipase, are intimately involved in HDL metabolism 1
  • Paraoxonase 1 (PON1) is an HDL-associated protein with esterase and lactonase enzyme activity that helps metabolize toxic compounds and oxidized lipids 1
  • Larger HDL particle size is consistently associated with a decreased risk of coronary artery disease 1, 2
  • Cholesteryl ester transfer protein interacts with HDL and may transfer lipids from HDL to other lipoproteins, affecting overall serum lipid profiles 1

Clinical Significance of HDL

  • Low HDL cholesterol levels are considered a marker of increased cardiovascular risk, with the American Heart Association suggesting levels below 40 mg/dL in men and 45 mg/dL in women as indicative of higher risk 3
  • Optimal HDL levels, as recommended by the European Society of Cardiology, are considered protective against cardiovascular disease, with levels of 60 mg/dL or higher being desirable 6
  • The ratio of total cholesterol to HDL or LDL to HDL provides additional risk stratification beyond individual lipid measurements, according to the American College of Cardiology 4

HDL in Disease States

  • In patients with coronary artery disease, HDL often lacks endothelial anti-inflammatory properties, has lower PON1 enzyme activity, and does not effectively promote endothelial nitric oxide production 1
  • Endothelial lipase is upregulated during inflammation, a condition that increases LDL oxidation and atherogenesis, negatively affecting HDL function 1
  • In metabolic syndrome, HDL is often characterized by low HDL-C levels alongside hypertriglyceridemia, abdominal obesity, insulin resistance, and other metabolic irregularities 1, 2
  • The European Society of Cardiology notes that while low HDL is an established risk factor for cardiovascular disease, pharmacologic HDL-raising strategies have not consistently shown outcome benefits 6
  • In patients with type 2 diabetes, HDL may lose its protective properties due to alterations of the protein moiety, leading to a pro-oxidant, inflammatory phenotype 5

HDL vs. Other Lipoproteins

  • Unlike LDL, HDL is protective against atherosclerotic cardiovascular disease, as stated by the American Heart Association 4
  • Non-HDL cholesterol may be a better predictor of cardiovascular risk than LDL alone, especially in patients with elevated triglycerides, according to the European Society of Cardiology 6
  • LDL transports cholesterol to peripheral tissues and can deposit in arterial walls, promoting plaque formation, while HDL removes excess cholesterol from these tissues 4
  • Small, dense LDL particles are more susceptible to lipid peroxidation and are considered more atherogenic than larger LDL particles 1, 2
  • The European Society of Cardiology identifies both low HDL cholesterol and high LDL cholesterol as key risk factors for cardiovascular disease 6, 3